Novel ruthenium antimicrobial compounds.
Through exploitation of new chemical space, two antimicrobial complexes have been developed.
High activities on priority pathogens, antimicrobial efficacy and low toxicity in-vivo and ex-vivo. Low emergence of resistance and a novel target.
- Antimicrobial compounds
- Alternative antimicrobials
- License, Co-develop, Outsource, Joint Venture
We would like a partner to advise and assist on the next stages of our pre-clinical development plan.
Metallobio are a prospective spin out company from the University of Sheffield developing two novel antimicrobial compounds.